Starling Oncology, Inc. Common Stock STLN

$4.20 -3.23% at last close

Market Cap$442.64 million

P/E Ratio—

Div Yield—

Volume2.97M

52-Week Range

$3.35$7.13

Analyst Ratings

Consensus: Buy — 4 Buy · 0 Hold · 0 Sell (4 analysts)
Avg. Price Target: $9.25 (+120.2% upside)

Full STLN forecast & analyst actions →

Key Stats

Today's Range: $4.16 – $4.81
50-Day Range: $3.35 – $7.13
52-Week Range: $3.35 – $7.13
Volume: 2.97 million shs
Average Volume: 2.52 million shs
Market Cap: $442.64 million
P/E Ratio: —
Dividend Yield: —

Short Interest

Short Interest: 6.89%
Days to Cover: 3.51

About Starling Oncology, Inc. Common Stock

Starling Oncology Inc provides oncology care services in community settings. Its services include cancer diagnosis and treatment, clinical trials, transfusion services, and other oncology care delivery models for patients.

Sector: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE
Employees: 641
Exchange: XNAS
Listed: 2021-11-15
Website: www.starlingoncology.com

Related Stocks

Compare head-to-head: STLN vs HIMS·STLN vs TDOC·STLN vs AIRS·STLN vs LFMD

Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.